Stock screener

TXG

Conviction 81IndustrialsScan · Tue, Sep 8, 2026
TXG$65.56+4.64%
ResistanceSupportVol 14Insider sell
63 bars
3
5
2
4
2
Vol MA14 2.79M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
10x Genomics, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.10xgenomics.com
Price65.56
Change+4.64%
Gap-1.04%
Rel volume1.06×
Avg volume2.81M
Avg $ vol173.48M
SMA 2061.50
SMA 5051.45
SMA 20029.19
Price vs 50+27.43%
Price vs 200+124.61%
MA stackbullish
50/200 cross
Supertrendup · 53.23
RSI (14)65
MACD hist-0.51
MACD crossbear · 6d
Stoch %K / %D85 / 72
ADX (14)43
+DI / −DI26 / 10
RSI divergence
MACD divergence
ATR %+5.52%
ADR %5.67%
52w high65.56
52w low11.34
From 52w high+0.00%
Above 52w low+478.13%
New 52w highYes
SqueezeOff
Bollinger width19.95%
%B0.83
Donchian pos88.20%
Donchian high66.94
Donchian low55.25
AVWAP (52w high)63.13
vs AVWAP high+3.85%
AVWAP (52w low)28.09
vs AVWAP low+133.35%
OBV trendFlat
Chaikin MF (20)0.24
Today vs 20d1.06×
Avg vol (14d)2.79M
Avg vol (20d)2.81M
Avg $ vol (20d)173.48M
Market cap
RS 3m (vs SPY)+97.41%
RS 6m (vs SPY)+186.51%
RS line new highNo
Trend template8/8
Technical rank95.8
1 week+4.98%
1 month+26.00%
3 months+124.67%
6 months+213.53%
1 year+369.63%
YTD+294.46%
P/E-183.72
P/B9.69
P/S12.44
P/FCF61.48
EPS-0.3500
Div yield
ROE-5.27%
ROA-4.23%
Debt/Eq0.00
Current5.69
EV/EBITDA-308.88
Gross margin69.05%
Net margin-6.77%
Rev growth5.25%
EPS growth76.16%
Price target52.00
Target upside-17.00%
Analyst ratingHold
Institutional119.15%
Ent. value7.66B
Revenue151.04M
Net income-17.93M
Gross profit112.5M
Free cash flow130.12M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out116.88M
Employees1.18K
ListedThu, Sep 12, 2019
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction81 / 100
Pattern quality
Tech rank95.8 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance63.82
Support41.93
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TXG

All disclosures →
No recent disclosed trades by Congress in TXG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TXG · 10 sells

InsiderSideShares
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-08-26
Sell3.5K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-08-26
Sell6.49K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-08-26
Sell492
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-08-24
Sell1.65K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-08-24
Sell18.55K
Taich Adam
Chief Financial Officer · Class A Common Stock · 2026-08-24
Sell17.17K
Hindson Benjamin J.
See Remarks · Class A Common Stock · 2026-08-24
Sell13.82K
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-08-24
Sell561
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-08-20
Gift4K
Teichmann Sarah A.
Director · Class A Common Stock · 2026-08-14
Sell2.27K

SEC filings

EDGAR filings in TXG · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.